Blood Advances, 2023
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204)

Phillips T., Avigdor A., Gurion R. et al.

Cancer Research Communications, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Munster P., Iannotti N., Cho D. et al.

eBioMedicine, 2023
Circulating biomarkers in familial cerebral cavernous malformation

Lazzaroni F., Meessen J., Sun Y. et al.

International Journal of Molecular Sciences, 2023
Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis

Szabo I., Badii M., Gaál I. et al.

European Journal of Neuroscience, 2023
Proximity extension assay‐based proteomics studies in neurodegenerative disorders and multiple sclerosis

Arioz B., Cotuk A., Yaka E. et al.

Scientific Reports, 2023
Inflammatory protein signatures in individuals with obesity and metabolic syndrome

Mir F., Abdesselem H., Cyprian F. et al.

Menopause, 2023
The menopause-related gut microbiome: associations with metabolomics, inflammatory protein markers, and cardiometabolic health in women with HIV

Wang Y., Sharma A., Weber K. et al.

Journal of the Association for Research in Otolaryngology, 2023
Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus

Cederroth C., Hong M., Freydin M. et al.

Investigative Opthalmology & Visual Science, 2023
Tear Fluid Inflammatory Proteome Analysis Highlights Similarities Between Keratoconus and Allergic Conjunctivitis

Gijs M., Adelaar T., Vergouwen D. et al.

Scientific Data, 2023
A dataset of proteomic changes during human heat stress and heat acclimation

Gagnon D., Barry H., Barhdadi A. et al.

OncoImmunology, 2023
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases

Li M., Chen J., Yu H. et al.

Diabetes Care, 2023
Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk

Wang H., Chong M., Perrot N. et al.

Nature, 2023
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

LaMarche N., Hegde S., Park M. et al.

International Archives of Allergy and Immunology, 2023
Comparing Protein and Gene Expression Signature between Nasal Polyps and Nasal Fluids in Chronic Rhinosinusitis

Hou Y., Chen C., Li Z. et al.

Cardiology and Therapy, 2023
Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery Disease

Groh L., Willems L., Fintelman P. et al.

Clinical Cancer Research, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer

Bessede A., Peyraud F., Besse B. et al.

Blood Advances, 2023
Clinical and immunological features in ACKR1/DARC-associated neutropenia

Palmblad J., Sohlberg E., Nilsson C. et al.

European Journal of Heart Failure, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials

Ferreira J., Butler J., Anker S. et al.

eBioMedicine, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial

Zhang X., Irajizad E., Hoffman K. et al.

Scientific Reports, 2023
Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome

Goudswaard L., Smith M., Hughes D. et al.